SciELO - Scientific Electronic Library Online

 
vol.52 issue2Temporal lobe epilepsy and aura with happiness and pleasure: report of two cases and literature revisionHemiballismus as a first manifestation of acquired immunodeficiency syndrome: case report author indexsubject indexarticles search
Home Pagealphabetic serial listing  

Arquivos de Neuro-Psiquiatria

Print version ISSN 0004-282X

Abstract

GHERPELLI, José Luiz Dias; LUCCAS, Francisco José C.; ROITMAN, Israel  and  TROSTER, Eduardo Juan. Midazolam for treatment of refractory neonatal seizures: a case report. Arq. Neuro-Psiquiatr. [online]. 1994, vol.52, n.2, pp. 260-262. ISSN 0004-282X.  http://dx.doi.org/10.1590/S0004-282X1994000200019.

Midazolam is a short-acting water soluble benzodiazepine that has been used with an increasing frequency in the last years. Although there are reports on its use in status epilepticus, there is none in the neonatal period. A pre-term (35 w) AGA newborn infant with a severe hypoxic-ischemic encephalopathy secondary to grade ED hyaline membrane disease developed status epilepticus in the first 6 hours of life and was successfully treated with midazolam after phenobarbital and phenytoin failed to achieve seizure control. Dosage schedule was 0.2 mg/kg IV, followed by continuous infusion of 0.025 mg/kg/h. Midazolam is an effective drug for neonatal status epilepticus and more experience should accumulate before it can be routinely employed in the neonatal period. This case shows that it is a possible option before using more dangerous drugs, such as thionembutal.

Keywords : status epilepticus; neonatal seizure; high risk newborn infant; neonatal hypoxic-ischemic encephalopathy.

        · abstract in Portuguese     · text in English     · pdf in English